What goes into validation of assays for biomarkers that can help your organization make decisions in the drug development process? Tim Lansing, of BioAgilytix, offers his expert opinion in this Virtual Podium presentation.
Tim has twenty years of drug discovery and cell-based assay development experience in the pharmaceutical industry at GlaxoSmithKline and is an expert in ELISA, EIA, ECL, and luciferase assay platforms. At BioAgilytix Labs, Tim has been the project manager for the bioanalysis of clinical samples for more than 10 Phase I/II clinical trials of metabolic assets and for cell-based assays for lot comparison and product release under GMP.
Services
Platforms
